# Efficacy and Safety of Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infection

> **NCT06051513** · NA · RECRUITING · sponsor: **Southeast University, China** · enrollment: 404 (estimated)

## Conditions studied

- Carbapenem-Resistant Enterobacteriaceae Infection

## Interventions

- **DRUG:** treatment with or without colistin

## Key facts

- **NCT ID:** NCT06051513
- **Lead sponsor:** Southeast University, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-27
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 404 (ESTIMATED)
- **Last updated:** 2025-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06051513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06051513, "Efficacy and Safety of Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infection". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06051513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*